Cargando…

Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales:	Machiels, M., Weytjens, R., Bauwens, W., Vingerhoed, W., Billiet, C., Huget, P., Verellen, D., Dirix, P., Meijnders, P., Poortmans, P., Kaidar-Person, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal College of Radiologists. Published by Elsevier Ltd. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834150/ https://www.ncbi.nlm.nih.gov/pubmed/33309183 http://dx.doi.org/10.1016/j.clon.2020.11.027

Ejemplares similares

The use of simulation-CT’s as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic()
por: Nevens, Daan, et al.
Publicado: (2020)

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables
por: Billiet, Charlotte, et al.
Publicado: (2022)

Comparing treatment uncertainty for ultra- vs. standard-hypofractionated breast radiation therapy based on in-vivo dosimetry
por: Fiagan, Yawo A.C., et al.
Publicado: (2022)

A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)
por: Mercier, Carole, et al.
Publicado: (2018)

Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2021)

Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer()
por: Poortmans, Philip M.P., et al.
Publicado: (2019)

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation
por: Benitez, Cecil M., et al.
Publicado: (2023)

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
por: Salgado, R, et al.
Publicado: (1999)

Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases
por: Billiet, Charlotte, et al.
Publicado: (2020)

Machine learning-based treatment couch parameter prediction in support of surface guided radiation therapy
por: De Kerf, Geert, et al.
Publicado: (2022)

The King is in the altogether: Radiation therapy after oncoplastic breast surgery
por: Kaidar-Person, Orit, et al.
Publicado: (2023)

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer
por: Dirix, L Y, et al.
Publicado: (2002)

Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era
por: Griffiths, W., et al.
Publicado: (2021)

Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)
por: Gasparri, Maria Luisa, et al.
Publicado: (2020)

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer
por: Salgado, R, et al.
Publicado: (2002)

Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials
por: Marta, Gustavo Nader, et al.
Publicado: (2022)

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic
por: Coles, C.E., et al.
Publicado: (2020)

Obstetric complications at time of delivery amongst breast cancer survivors: A population-based cohort study
por: Kaidar-Person, Orit, et al.
Publicado: (2022)

Breast cancer radiation therapy: A bibliometric analysis of the scientific literature
por: Franco, Pierfrancesco, et al.
Publicado: (2022)

Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry
por: Bossuyt, Evy, et al.
Publicado: (2023)

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
por: Mercier, Carole, et al.
Publicado: (2019)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients
por: Ishiyama, Hiromichi, et al.
Publicado: (2021)

Team Work: Mastectomy, Reconstruction, and Radiation
por: Kaidar-Person, Orit, et al.
Publicado: (2017)

COVID-RO study: the radiation oncology practice at times of COVID-19 outbreak — international survey
por: Appel, Sarit, et al.
Publicado: (2021)

Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer
por: Mohajer, Jonathan, et al.
Publicado: (2020)

Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
por: Wolf, Frank, et al.
Publicado: (2020)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
por: Hong, Yejun, et al.
Publicado: (2023)

One-Year Toxicity of Ultrahypofractionated Breast Radiotherapy (+/- Sequential Boost) and a Survey of Patient Experience
por: Nicholson, J., et al.
Publicado: (2022)

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients – reply
por: Salgado, R, et al.
Publicado: (2000)

Adapting training for medical physicists to match future trends in radiation oncology()
por: Clark, Catharine H., et al.
Publicado: (2019)

The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review
por: Marta, Gustavo Nader, et al.
Publicado: (2020)

Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges
por: Kaidar-Person, Orit, et al.
Publicado: (2021)

Evaluation of automated pre-treatment and transit in-vivo dosimetry in radiotherapy using empirically determined parameters
por: Bossuyt, Evy, et al.
Publicado: (2020)

Model Calibration of Pharmacokinetic-Pharmacodynamic Lung Tumour Dynamics for Anticancer Therapies
por: Ghita, Maria, et al.
Publicado: (2022)

Lymphoepithelioma-Like Carcinoma of the Salivary Gland: Is Radiotherapy Alone Adequate?
por: Kaidar-Person, Orit, et al.
Publicado: (2011)

Linac-Based Ultrahypofractionated Partial Breast Irradiation (APBI) in Low-Risk Breast Cancer: First Results of a Monoinstitutional Observational Analysis
por: Merten, Roland, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t9a00envdjb3kngj2lbjugqvb5